Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases.

被引：0
|
作者：
Aoyama, H
Shirato, H
Nakagawa, K
Tago, M
机构：
[1] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
[2] Univ Tokyo, Sch Med, Tokyo 113, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1506
引用
收藏
页码：108S / 108S
页数：1
相关论文
共 49 条
  • [41] Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole Brain Radiation Therapy (WBRT) Versus WBRT Plus Stereotactic Radiosurgery (SRS) in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
    Sperduto, P. W.
    Shanley, R.
    Luo, X.
    Andrews, D.
    Werner-Wasik, M.
    Valicenti, R.
    Bahary, J.
    Souhami, L.
    Won, M.
    Mehta, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S51 - S52
  • [42] RTOG 0320:A phase Ill trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases
    Sperduto, Paul W.
    Wang, Meihua
    Robins, H. Ian
    Schell, Michael C.
    Werner-Wasik, Maria
    Komaki, Ritsuko U.
    Souhami, Luis
    Buyyounouski, Mark K.
    Khuntia, Deepak
    Demas, William F.
    Shah, Sunjay A.
    Nedzi, Lucien A.
    Perry, G. A.
    Suh, John H.
    Mehta, Minesh P.
    CANCER RESEARCH, 2012, 72
  • [43] A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT & SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
    Robins, H. Ian
    O'Neill, Anne
    Mehta, Minesh
    Grossman, Stuart
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 809 - 810
  • [44] A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
    Sperduto, Paul W.
    Wang, Meihua
    Robins, H. Ian
    Schell, Michael C.
    Werner-Wasik, Maria
    Komaki, Ritsuko
    Souhami, Luis
    Buyyounouski, Mark K.
    Khuntia, Deepak
    Demas, William
    Shah, Sunjay A.
    Nedzi, Lucien A.
    Perry, Gad
    Suh, John H.
    Mehta, Minesh P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1312 - 1318
  • [45] A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT & SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320 Reply
    Sperduto, Paul W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 810 - 810
  • [46] Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial
    Bernhardt, D.
    El Shafie, R.
    Thomas, M.
    Bozorgmehr, F.
    Schiele, A.
    Schmitt, D.
    Welzel, T.
    Thalmann, P.
    Paul, A.
    Koenig, L.
    Lang, K.
    Adeberg, S.
    Hoene, S.
    Weykamp, F.
    Vollmuth, P.
    Lentz-Hommertgen, A.
    Jaekel, C.
    Nestle, U.
    Kieser, M.
    Debus, J.
    Rieken, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : E5 - E5
  • [47] Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
    Nakanishi, Koki
    Kobayashi, Daisuke
    Mochizuki, Yoshinari
    Ishigure, Kiyoshi
    Ito, Seiji
    Kojima, Hiroshi
    Ishiyama, Akiharu
    Fujitake, Shinichi
    Shikano, Toshio
    Morita, Satoshi
    Kodera, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 557 - 565
  • [48] Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
    Koki Nakanishi
    Daisuke Kobayashi
    Yoshinari Mochizuki
    Kiyoshi Ishigure
    Seiji Ito
    Hiroshi Kojima
    Akiharu Ishiyama
    Shinichi Fujitake
    Toshio Shikano
    Satoshi Morita
    Yasuhiro Kodera
    International Journal of Clinical Oncology, 2016, 21 : 557 - 565
  • [49] QUALITY OF LIFE RESULTS OF AN EORTC PHASE III RANDOMIZED TRIAL OF ADJUVANT WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES OF SOLID TUMORS
    Soffietti, Riccardo
    Mueller, Rolf P.
    Abacioglu, Ufuk
    Villa, Salvador
    Fauchon, Francois
    Baumert, Brigitta
    Fariselli, Laura
    Tridello, Gloria
    Kocher, Martin
    Bottomley, Andrew
    NEURO-ONCOLOGY, 2010, 12 : 101 - 101
12345